Cleveland Clinic, RIKEN and IBM Team Advance to Finals for 2026 ACM Gordon Bell Prize

{
  "signal_id": "56a2aa8b-fd96-fb69-57ef-d4870b3f992d",
  "signal_type": "news",
  "signal_subtype": "partners_with",
  "detected_at": "2026-09-09T04:00:00+00:00",
  "company": {
    "name": "Cleveland Clinic",
    "domain": "clevelandclinic.org"
  },
  "data": {
    "url": "https://www.prnewswire.com/news-releases/cleveland-clinic-riken-and-ibm-team-advance-to-finals-for-2026-acm-gordon-bell-prize-302872821.html",
    "title": "Cleveland Clinic, RIKEN and IBM Team Advance to Finals for 2026 ACM Gordon Bell Prize",
    "excerpt": "Joint research team modeled a 12,635-atom protein, the largest-known to be simulated using quantum computers. Breakthrough was achieved through quantum and classical methods working together, expanding quantum-centric supercomputing's potential in life sciences research. CLEVELAND and WAKO, Japan and YORKTOWN HEIGHTS, N.Y. , Sept. 9, 2026 /PRNewswire/ -- A multidisciplinary team from Cleveland Clinic, RIKEN and IBM (NYSE: IBM ) has been named as a finalist for the 2026 Association for Computing Machinery (ACM) Gordon Bell Prize for simulating the largest biologically meaningful molecules ever modeled with quantum computers, reaching a scale of 12,635 atoms. To achieve these results, the team united the strengths of quantum and classical computing methods in a framework known as quantum-centric supercomputing. The ACM Gordon Bell Prize recognizes outstanding achievement in high-performance computing and is one of the field's most prestigious honors. The 2026 winner will be announced at the International Conference for High-Performance Computing, Networking, Storage, and Analysis (SC26), taking place Nov. 15–20, 2026 in Chicago. The origins of the project are rooted in the team's investigation into how computation in drug discovery can be improved. Doing so rests on two fundamental challenges: first, modeling the movement of atoms as biological processes unfold; and second...",
    "summary": "Cleveland Clinic, RIKEN, and IBM have formed a joint research team that has been named a finalist for the 2026 ACM Gordon Bell Prize for simulating large biological molecules using quantum computers.",
    "location": "Cleveland, Ohio, USA",
    "planning": false,
    "image_url": "https://mmx.prnewswire.com/media/MS654328/IBM-LOGO-1.jpg?id=OA2936388&p=facebook",
    "confidence": 0.9,
    "published_at": "2026-09-09T04:00:00Z",
    "location_data": [
      {
        "city": "Cleveland",
        "state": "Ohio",
        "region": "Northern America",
        "country": "United States",
        "continent": "Americas",
        "fuzzy_match": false
      }
    ],
    "article_sentence": "9, 2026 /PRNewswire/ -- A multidisciplinary team from Cleveland Clinic, RIKEN and IBM (NYSE: IBM ) has been named as a finalist for the 2026 Association for Computing Machinery (ACM) Gordon Bell Prize for simulating the largest biologically meaningful molecules ever modeled with quantum computers, reaching a scale of 12,635 atoms.",
    "related_company_name": "RIKEN",
    "related_company_domain": "riken.jp"
  }
}

curl https://signals.autobound.ai/v1/signals/56a2aa8b-fd96-fb69-57ef-d4870b3f992d \
  -H "X-API-KEY: $AUTOBOUND_API_KEY"

curl -X POST https://signals.autobound.ai/v1/companies/enrich \
  -H "X-API-KEY: $AUTOBOUND_API_KEY" \
  -H "Content-Type: application/json" \
  -d '{"domain":"clevelandclinic.org","limit":20}'